(Q34590796)

3 August 2017

1 reference

title

Current and future strategies for combined-modality therapy in pancreatic cancer (English)

1 reference

3 August 2017

1 reference

Andrew H Ko

1

1 reference

3 August 2017

Margaret A Tempero

series ordinal

2

1 reference

3 August 2017

language of work or name

1 reference

1 May 2002

1 reference

3 August 2017

published in

Current Oncology Reports

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

202-212

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-002-0017-Z

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

21 January 2018

1 reference

12 December 2020

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

1 reference

12 December 2020

Radiosensitization of human tumor cells by gemcitabine in vitro

1 reference

12 December 2020

Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer

1 reference

12 December 2020

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

12 December 2020

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer

1 reference

12 December 2020

Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer

1 reference

12 December 2020

High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)

1 reference

12 December 2020

Extended radical resection of cancer of the pancreas with intraoperative radiotherapy

1 reference

12 December 2020

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

12 December 2020

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

1 reference

12 December 2020

A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas

1 reference

12 December 2020

Paclitaxel and concurrent radiation for locally advanced pancreatic cancer

1 reference

12 December 2020

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

1 reference

12 December 2020

Neoadjuvant strategies for pancreatic cancer

1 reference

12 December 2020

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

1 reference

12 December 2020

Studies of intraoperative radiotherapy in carcinoma of the pancreas

1 reference

12 December 2020

Intraoperative irradiation combined with radical resection for cancer of the head of the pancreas

1 reference

12 December 2020

A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer

1 reference

12 December 2020

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

12 December 2020

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience

1 reference

12 December 2020

Chemoradiation for pancreatic and biliary cancer: current status of RTOG studies

1 reference

12 December 2020

Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group

1 reference

12 December 2020

Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma

1 reference

12 December 2020

Adjuvant therapy of resected adenocarcinoma of the pancreas

1 reference

12 December 2020

Combined modality therapy for stage II and stage III pancreatic carcinoma

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer

1 reference

12 December 2020

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head

1 reference

12 December 2020

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

1 reference

12 December 2020

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Synergistic interaction between cisplatin and gemcitabine in vitro.

1 reference

12 December 2020

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma

1 reference

12 December 2020

Adjuvant therapy for pancreatic cancer: current treatment approaches and future challenges

1 reference

12 December 2020

Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil

1 reference

12 December 2020

Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole

1 reference

12 December 2020

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer

1 reference

12 December 2020

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

12 December 2020

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas

1 reference

12 December 2020

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

12 December 2020

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

1 reference

12 December 2020

Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.

1 reference

12 December 2020

Recurrence after resection for ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

10.1007/S11912-002-0017-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1049174528

0 references

Fatcat ID

release_h2pb6bg7rba7hh5fyv4tibtela

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h2pb6bg7rba7hh5fyv4tibtela

24 November 2022

mapped directly with Wikidata item

1 reference